{"title": "Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases", "doi": "10.1101/2020.03.09.20032219", "citation_id": "2020.03.09.20032219v2", "date": "2020-03-20", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.09.20032219", "abstract": "<p>The outbreak of COVID-19 epidemic has caused worldwide health concerns since Nov., 2019. A previous study described the demographic, epidemiologic, and clinical features for infected infants. However, compared with adult cases, little attention has been paid to the infected pediatric cases. Severity detection is challenging for children since most of children patients have mild symptoms no matter they are moderately or critically ill therein.</p>", "twitter_description": "The outbreak of COVID-19 epidemic has caused worldwide health concerns since Nov., 2019. A previous study described the demographic, epidemiologic, and clinical features for infected infants. However, compared with adult cases, little attention has been paid to the infected pediatric cases. Severity detection is challenging for children since most of children patients have mild symptoms no matter they are moderately or critically ill therein.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNone\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nNone", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032219v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032219v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20032219v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/20/2020.03.09.20032219.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.09.20032219v2", "access_rights": "restricted", "authors": ["Hui Yu", "Jianbo Shao", "Yuqi Guo", "Yun Xiang", "Chuan Sun", "Ye Yuan"]}